Other languages Exopharm Limited

Equities

EX1

AU0000030975

Market Closed - Australian S.E. Other stock markets 08:10:45 2023-10-01 pm EDT			5-day change	1st Jan Change
0.0275 ^AUD	+10.00%		-.--%	-.--%

Feb. 26	Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	Exopharm to Cut CEO Role Amid Cost Reductions	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 26
Exopharm Limited Announces Ian Dixon's Employment as CEO Expects to End in Early Calendar Year 2024	Nov. 27
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-28
Exopharm Limited Announces Executive Changes	23-06-21
Exopharm Achieves Initial Success With Exosome Products; Shares Fall 21%	23-04-28
Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26
Exopharm Limited Announces Board Changes	23-02-22
Exopharm Limited Announces Resignation of Elizabeth McGregor as Non-Executive Director	22-12-20
Sartorius BIA Separations and Exopharm Ltd Testing the Synergy of Exopharm's Patented LEAP Technology Together with Bia's Unique Cim (Convective Interaction Media) Monolith Chromatography for Improved Large- Scale Exosome Production and Commercialization	22-11-16
Exopharm Limited Will Commence LEAP Technology Transfer to AIRM under MSA	22-11-13
Exopharm Limited Announces Study Results Indicate Exosomes Safe for Clinical Pursuit	22-09-27
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-30
Exopharm Limited Auditor Raises 'Going Concern' Doubt	22-08-29
Exopharm Enters Loan Agreement for Early Access to R&D Tax Rebate	22-06-16
Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-24
Exopharm, AIRM Enter Collaborative Services Agreement	22-01-31
Exopharm Limited Signs Master Collaborative Services Agreement with the Astellas Institute for Regenerative Medicine	22-01-30
Exopharm Gets US Patent for Drug Delivery Technology	21-12-21
Exopharm : Widens After-Tax Loss in FY21; Shares Jump 6%	21-08-29
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Exopharm Limited

Equities

EX1

AU0000030975

Other languages

Filters